The dDATcryst construct (Supplementary Fig. 1) was expressed in virus-infected mammalian cells and purified by affinity and size-exclusion chromatography. Fab 9D5 was added prior to crystallization along with nortriptyline (1mM) at a DAT:Fab molar ratio of 1:1.1 and concentrated down to 3 mg/ml. Crystals of the complex were obtained in the presence of 100 mM glycine pH 9 and 38% PEG 350 MME. The structure was solved by molecular replacement using a poly-alanine model of LeuT (PDB id. 3F3A) and an ensemble of Fab variable and constant domains. Data processing, model building, and refinement were performed using standard crystallographic software (Supplementary Table 1).